Literature DB >> 19628432

Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.

Patrice D Cani1, Nathalie M Delzenne.   

Abstract

Obesity and associated metabolic disorders are worldwide epidemic. The literature provides new evidence that gut microbiota dysbiosis (at the phyla, genus, or species level) affects host metabolism and energy storage. Here we discuss new findings that may explain how gut microbiota can be involved in the development or in the control of obesity and associated low-grade inflammation. New powerful molecular biology methods and the use of gnotobiotic animal allowed to analyze the molecular link between gut bacteria and the host. Moreover, even if more studies are needed to unravel how changing gut microbiota impacts on the development of obesity and related metabolic alterations, probiotic and prebiotic approach appear as potential interesting treatments to reverse host metabolic alterations linked to gut microbiota dysbiosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628432     DOI: 10.1016/j.coph.2009.06.016

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  108 in total

Review 1.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Authors:  Nina Sanapareddy; Ryan M Legge; Biljana Jovov; Amber McCoy; Lauren Burcal; Felix Araujo-Perez; Thomas A Randall; Joseph Galanko; Andrew Benson; Robert S Sandler; John F Rawls; Zaid Abdo; Anthony A Fodor; Temitope O Keku
Journal:  ISME J       Date:  2012-05-24       Impact factor: 10.302

Review 3.  The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.

Authors:  Yury I Miller; Soo-Ho Choi; Philipp Wiesner; Yun Soo Bae
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Changes in anthropometric measurements, body composition, blood pressure, lipid profile, and testosterone in patients participating in a low-energy dietary intervention.

Authors:  Mary Balliett; Jeanmarie R Burke
Journal:  J Chiropr Med       Date:  2013-03

5.  Safety Evaluation and In vivo Strain-Specific Functionality of Bacillus Strains Isolated from Korean Traditional Fermented Foods.

Authors:  Haryung Park; Myungki Lee; Dahye Jeong; Soyoung Park; Yosep Ji; Svetoslav D Todorov; Wilhelm H Holzapfel
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

Review 6.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

7.  Dangerous disappearing act: commensal gut microbiota after acute severe insults.

Authors:  Joe Alcock
Journal:  Dig Dis Sci       Date:  2011-08       Impact factor: 3.199

Review 8.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

9.  Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects.

Authors:  Inés Martínez; Jaehyoung Kim; Patrick R Duffy; Vicki L Schlegel; Jens Walter
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 10.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.